The following risk minimisation materials are available:
• Educational Materials for Healthcare Professionals• Caprelsa (Vandetanib) Dosing and Monitoring Guide for Patients and Patients’ Caregivers (paediatric use)• The Patient Alert Card
They have been updated and now include specific information on the risks associated with the paediatric population and also include paediatric dosing information tailored for both the healthcare professional and the patient and their caregiver.